drugset / Trial / NCT01682837

Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension

NCT01682837

Phase 2 Completed 35 enrolled University of Texas Southwestern Medical Center
RandomizedCrossoverQuadruple-blindTreatment

Summary

Liquid potassium-magnesium citrate (KMgCit) as a pharmaceutical formulation will lower blood pressure among patients with pre- or Stage I hypertension on their customary diet.

Timeline

Start
2012-10
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject POTASSIUM MAGNESIUM CITRATE (4:1:2) Small molecule 20 meq
Subject Potassium chloride powder Unknown 20 meq
Subject Potassium citrate powder Unknown 20 meq

Indications